Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Adjuvant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02586025
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel

Who this might be right for
Breast Cancer
Hoffmann-La Roche 329
Testing effectiveness (Phase 2)WithdrawnNCT05178576
What this trial is testing

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Who this might be right for
Colon Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT05684276
What this trial is testing

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

Who this might be right for
NSCLCPancoast Tumor
Fundación GECP 22
Large-scale testing (Phase 3)Study completedNCT01317108
What this trial is testing

Prognostic and Predictive Impact of uPA/PAI-1

Who this might be right for
Breast Cancer
Universitätsklinikum Hamburg-Eppendorf 689
Not applicableStudy completedNCT04368468
What this trial is testing

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Who this might be right for
Triple Negative Breast Cancer
Institut Claudius Regaud 100
Large-scale testing (Phase 3)Study completedNCT00132301
What this trial is testing

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

Who this might be right for
Prostate Cancer
VA Office of Research and Development 298
Large-scale testing (Phase 3)UnknownNCT00005581
What this trial is testing

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,000
Not applicableStudy completedNCT06299930
What this trial is testing

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 10,328
Large-scale testing (Phase 3)UnknownNCT03654534
What this trial is testing

Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy

Who this might be right for
Gastric Cancer
Sun Yat-sen University 374
Large-scale testing (Phase 3)Looking for participantsNCT04997837
What this trial is testing

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
Fudan University 433
Testing effectiveness (Phase 2)Active Not RecruitingNCT03820063
What this trial is testing

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 462
Testing effectiveness (Phase 2)UnknownNCT01929499
What this trial is testing

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer

Who this might be right for
Colonic Neoplasms
Yanjuan Zhu 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605535
What this trial is testing

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialOvarian CancerFallopian Tube Neoplasms+2 more
CanariaBio Inc. 88
Not applicableNot Yet RecruitingNCT07749924
What this trial is testing

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Who this might be right for
Bladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)
Tianjin Medical University Second Hospital 670
Not applicableEnrolling By InvitationNCT07549685
What this trial is testing

Music Therapy in Patients With Breast Cancer (IMPACT)

Who this might be right for
Breast Cancer
Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di Alessandria 24
Large-scale testing (Phase 3)Study completedNCT03013010
What this trial is testing

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

Who this might be right for
Stomach NeoplasmGastroEsophageal CancerAdenocarcinoma+2 more
Shanghai Cancer Hospital, China 204
Large-scale testing (Phase 3)Looking for participantsNCT05813015
What this trial is testing

Study of Comparing of With and Without Sequential Therapy of S-1

Who this might be right for
Locally Advanced Gastric AdenocarcinomaChemotherapy Effect
Zhejiang University 70
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Large-scale testing (Phase 3)UnknownNCT01906814
What this trial is testing

Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation

Who this might be right for
Retinoblastoma
Sun Yat-sen University 179
Testing effectiveness (Phase 2)Looking for participantsNCT05825443
What this trial is testing

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients

Who this might be right for
ImmunotherapyChemotherapy
Nanfang Hospital, Southern Medical University 57
Next Page